FDA Orders New Warning Labels for Ozempic and Wegovy Over Rare Risk of Permanent Vision Loss
The FDA now requires Ozempic, Wegovy and other GLP-1 drugs to warn about NAION, a rare eye condition linked to permanent vision loss. Here’s what changed.
Read More : FDA Orders New Warning Labels for Ozempic and Wegovy Over Rare Risk of Permanent Vision Loss